Myeloma-Developing Regimens Using Genomics (MyDRUG)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hearn J Cho, M.D., Ph.D.
Multiple Myeloma Research Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic - Arizona
Phoenix, Arizona, United States
- City of Hope
Duarte, California, United States
- Emory University
Atlanta, Georgia, United States
- Beth Israel Deaconess
Boston, Massachusetts, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Karmanos Cancer Center
Detroit, Michigan, United States
- Mayo Clinic - Minnesota
Rochester, Minnesota, United States
- Washington University School of Medicine Division of Medical Oncology
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Mount Sinai School of Medicine
New York, New York, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Ohio State University College of Medicine
Columbus, Ohio, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2019
- Primary completion
- 31 Dec 2024
- Completion
- 31 Dec 2024
- Last update posted
- 14 Feb 2025
- Registered enrollment
- 103
- Registry id
- NCT03732703
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.